Net Income

By divesting its CTH casings unit to SARIA, Darling Ingredients is pruning its legacy assets to fund the renewable energy networks powering tomorrow's cities.

As Equity Bancshares prepares to unveil its Q3 2026 results, all eyes are on how strategic acquisitions and Midwest market dynamics are driving value.

As Swiss regulators impose punishing post-Credit Suisse capital buffers, a major shareholder is demanding UBS relocate to preserve $36 billion in market value.

As Duckhorn turns 50, the luxury wine giant reshapes its leadership to navigate industry headwinds, blending deep operational roots with commercial strategy.

A bold cash-conservation play by EPH European Property Holdings hits a procedural wall, exposing the friction of restructuring debt in a high-rate era.

As KeyBank brings on JPMorgan Chase veteran Drue Anderson to lead its retail operations, the regional lender signals a bold shift in its digital strategy.

In an industry plagued by 40% frontline turnover, IndiaFirst Life proves that employee retention is the ultimate driver of customer trust and profitability.

A historic winter drought halved Vail Resorts' profits. Now, the ski giant is betting on algorithmic efficiency and dynamic pricing to protect its bottom line.

By adding a MedPAC commissioner and a former Senator, Clover Health is building a board designed to navigate Washington's intense Medicare Advantage scrutiny.

By adding a sitting MedPAC commissioner and a former U.S. Senator to its board, Clover Health signals a strategic shift toward regulatory mastery.

BRI posted a massive IDR 31.2 trillion profit, proving that hyper-local retail deposits and strict MSME risk control can outmaneuver high interest rates.

Canada’s largest lender is aggressively optimizing its balance sheet, raising $2.6 billion in 48 hours while navigating a shifting post-CDOR rate climate.

Roborock's ascent to global dominance isn't just about vacuums. It is a masterclass in how AI-driven spatial mapping outmaneuvered legacy hardware.

As US policies freeze out Chinese biopharma, Altruist Biologics' flawless EMA audit reveals a pragmatic Europe prioritizing patient access over politics.

ABL Texcell Diagnostics’ phased acquisition of Vela’s US and Asian assets highlights a masterclass in post-pandemic medtech consolidation.

Gold.com executes a rare dual transition of its CFO and auditor. Here is how the $25 billion powerhouse navigated the SEC hurdles without missing a beat.

Chanson International's return to profitability relies heavily on shadow lending and extreme capital dilution, masking deep operational retail losses.

With a fortified balance sheet and a new leader, Carter Bank is making a strategic play for Raleigh's booming commercial sector. Is this a new era for the bank?

As Global Industrial's leadership prepares for key investor conferences, their real task is to sell a vision of digital resilience in a tangible world.

A stunning $1M profit in 4.5 months on a new acquisition isn't just a number. It's a challenge to the entire 'growth-at-all-costs' tech ethos.